Patterns of end-of-life hospital care for patients with non-Hodgkin lymphoma: exploring the landscape

References

• O'Connor NR, Hu R, Harris PS, et al. Hospice admissions for cancer in the final days of life: independent predictors and implications for quality measures. Jco. 2014;32:3184–3189.
   PubMed Web of Science ®Google Scholar
• Hui D, Bansal S, Park M, et al. Differences in attitudes and beliefs toward end-of-life care between hematologic and solid tumor oncology specialists. Ann Oncol. 2015;26:1440–1446.
   PubMed Web of Science ®Google Scholar
• Hui D, Didwaniya N, Vidal M, et al. Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer. 2014;120:1572–1578.
   PubMed Web of Science ®Google Scholar
• LeBlanc TW, Abernethy AP, Casarett DJ. What is different about patients with hematologic malignancies? A retrospective cohort study of cancer patients referred to a hospice research network. J Pain Symptom Manage. 2015;49:505–512.
   PubMed Web of Science ®Google Scholar
• Odejide OO, Cronin AM, Earle CC, et al. Hospice use among patients with lymphoma: impact of disease aggressiveness and curability. J Natl Cancer Inst. 2016;108:djv280.
   PubMedGoogle Scholar
• Steinhauser K, Christakis N, Clipp E, et al. Factors considered important at the end of life by patients, family, physicians, and other care providers. Jama. 2000;284:2476–2482.
   PubMed Web of Science ®Google Scholar
• Khan SA, Gomes B, Higginson IJ. End-of-life care-what do cancer patients want? Nat Rev Clin Oncol. 2014;11:100–108.
   PubMed Web of Science ®Google Scholar
• Earle C, Landrum M, Souza J, et al. Aggressiveness of cancer care near the end of life: is it a quality-of-care issue? J Clin Oncol. 2008;26:3860–3866.
   PubMed Web of Science ®Google Scholar
• Odejide OO, Cronin AM, Condron NB, et al. Barriers to quality end-of-life care for patients with blood cancers. J Clin Oncol. 2016;34:3126–3132.
   PubMed Web of Science ®Google Scholar
• Sexauer A, Cheng MJ, Knight L, et al. Patterns of hospice use in patients dying from hematologic malignancies. J Palliat Med. 2014;17:195–199.
   PubMed Web of Science ®Google Scholar
• Howell DA, Shellens R, Roman E, et al. Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and meta-analysis of published data. Palliat Med. 2011;25:630–641.
   PubMed Web of Science ®Google Scholar
• Fadul N, Elsayem A, Palmer JL, et al. Predictors of access to palliative care services among patients who died at a Comprehensive Cancer Center. J Palliat Med. 2007;10:1146–1152.
   PubMed Web of Science ®Google Scholar
• McGrath P, Holewa H. Special considerations for haematology patients in relation to end‐of‐life care: Australian findings. Eur J Cancer Care. 2007;16:164–171.
   PubMed Web of Science ®Google Scholar
• Zaorsky N, Churilla T, Egleston B, et al. Causes of death among cancer patients. Ann Oncol. 2017;28:400–407.
   PubMed Web of Science ®Google Scholar
• Wollongong U. International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM). 2012. Available from: http://nccc.uow.edu.au/icd10am/icd10am/index.html (cited 2012 Mar 23).
   Google Scholar
• Australian Bureau of Statistics. SEIFA: Socio-Economic Indexes for Areas. 2008. Available from: http://www.abs.gov.au/websitedbs/D3310114.nsf/home/Seifa_entry_page (cited 2012 Mar 23).
   Google Scholar
• Australian Bureau of Statistics. Australian Statistical Geography Standard (ASGS): Volume 5 - Remoteness Structure, July 2011 (cat. no. 1270.0.55.005). 2013. Available from: http://www.abs.gov.au/AUSSTATS/[email protected]/Lookup/1270.0.55.005Main+Features1July%202011?OpenDocument (cited 2015 May 27).
   Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130–1139.
   PubMed Web of Science ®Google Scholar
• Manitta V, Zordan R, Cole-Sinclair M, et al. The symptom burden of patients with hematological malignancy: a cross-sectional observational study. J Pain Symptom Manage. 2011;42:432–442.
   PubMed Web of Science ®Google Scholar
• Davis M, Temel J, Balboni T, et al. A review of the trials which examine early integration of outpatient and home palliative care for patients with serious illnesses. Ann Palliat Med. 2015;4:99–121.
   PubMed Web of Science ®Google Scholar
• Blackhall LJ, Read P, Stukenborg G, et al. CARE track for advanced cancer: impact and timing of an outpatient palliative care clinic. J Palliat Med. 2016;19:57–63.
   PubMed Web of Science ®Google Scholar
• Poulose JV, Do YK, Neo PSH. Association between referral-to-death interval and location of death of patients referred to a hospital-based specialist palliative care service. J Pain Symptom Manage. 2013;46:173–181.
   PubMed Web of Science ®Google Scholar
• Sundararajan V, Bohensky MA, Moore G, et al. Mapping the patterns of care, the receipt of palliative care and the site of death for patients with malignant glioma. J Neurooncol. 2014;116:119–126.
   PubMed Web of Science ®Google Scholar
• Odejide OO, Salas Coronado DY, Watts CD, et al. End-of-life care for blood cancers: a series of focus groups with hematologic oncologists. Jop. 2014;10:e396–e403.
   PubMedGoogle Scholar
• McCaughan D, Roman E, Smith AG, et al. Determinants of hospital death in haematological cancers: findings from a qualitative study. BMJ Support Palliat Care. 2018;8:78–86.
   PubMed Web of Science ®Google Scholar
• LeBlanc TW, Roeland EJ, El-Jawahri A. Early palliative care for patients with hematologic malignancies: is it really so difficult to achieve? Curr Hematol Malig Rep. 2017;12:300–308.
   PubMed Web of Science ®Google Scholar
• Button EB, Chan R, Chambers S, et al. A systematic review of prognostic factors at the end of life for people with a haematological malignancy. BMC Cancer. 2017;17:213.
   PubMed Web of Science ®Google Scholar
• Odejide OO, Cronin AM, Earle C, et al. Why are patients with blood cancers more likely to die without hospice? Cancer. 2017;123:3377–3384.
   PubMed Web of Science ®Google Scholar
• Collins A, McLachlan S, Philip J. Communication about palliative care: a phenomenological study exploring patient views and responses to its discussion. Palliat Med. 2018;32:133–142.
   PubMed Web of Science ®Google Scholar
• Smith J. Commentary: why do doctors overestimate? Bmj. 2000;320:472–473.
   PubMedGoogle Scholar
• Manitta VJ, Philip JA, Cole-Sinclair MF. Palliative care and the hemato-oncological patient: can we live together? A review of the literature. J Palliat Med. 2010;13:1021–1025.
   PubMed Web of Science ®Google Scholar
• LeBlanc TW, O'Donnell JD, Crowley-Matoka M, et al. Perceptions of palliative care among hematologic malignancy specialists: a mixed-methods study. Jop. 2015;11:e230–e238.
   PubMedGoogle Scholar
• El-Jawahri A, LeBlanc T, VanDusen H, et al. Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. Jama. 2016;316:2094–2103.
   PubMed Web of Science ®Google Scholar
• Zimmermann C. Palliative care for patients with hematological malignancies: time for a new model. Leuk Res. 2016;48:78.
   PubMed Web of Science ®Google Scholar
• Temel JS, Greer JA, El-Jawahri A, et al. Effects of early integrated palliative care in patients with lung and GI cancer: a randomized clinical trial. Jco. 2017;35:834–841.
   PubMedGoogle Scholar
• Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363:733–742.
   PubMed Web of Science ®Google Scholar
• Bakitas MA, Tosteson TD, Li Z, et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. Jco. 2015;33:1438–1445.
   PubMed Web of Science ®Google Scholar
• Higginson IJ, Bausewein C, Reilly CC, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med. 2014;2:979–987.
   PubMed Web of Science ®Google Scholar
• Zimmermann C, Swami N, Krzyzanowska M, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014;383:1721–1730.
   PubMed Web of Science ®Google Scholar
• Temel JS, Greer JA, Admane S, et al. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non–small-cell lung cancer: results of a randomized study of early palliative care. Jco. 2011;29:2319–2326.
   PubMedGoogle Scholar